United Therapeutics Corporation Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
United Therapeutics Corporation (UTHR) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$3.68 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-07-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2015-07-28
- United Therapeutics Corporation other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-06-30 was $1.56M, a 98.60% increase year-over-year.
- United Therapeutics Corporation other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2015-03-31 was -$5.24M.
- United Therapeutics Corporation other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-12-31 was -$30.00K, a 101.84% decline year-over-year.
- United Therapeutics Corporation other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2014-09-30 was -$2.53M.
- United Therapeutics Corporation other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was -$4.46M, a 690.85% decline from fiscal 2013.
- United Therapeutics Corporation other comprehensive income (loss), before reclassifications, net of tax for fiscal 2013 was $754.00K.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2015-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | -$3.68M 10-Q · filed 2015-07-28 | -$3.71M derived: sum of 3 quarters · filed 2015-07-28 | -$6.24M derived: sum of 4 quarters · filed 2015-07-28 |
| 2015-03-31 | -$5.24M 10-Q · filed 2015-04-28 | -$5.27M derived: sum of 2 quarters · filed 2015-04-28 | -$7.80M derived: sum of 3 quarters · filed 2015-04-28 | -$7.01M derived: sum of 4 quarters · filed 2015-04-28 |
| 2014-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$2.56M derived: sum of 2 quarters · filed 2015-02-24 | -$1.77M derived: sum of 3 quarters · filed 2015-02-24 | -$4.46M 10-K · filed 2015-02-24 |
| 2014-09-30 | -$2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | -$1.74M derived: sum of 2 quarters · filed 2014-10-28 | -$4.42M 10-Q · filed 2014-10-28 | -$2.80M derived: sum of 4 quarters · filed 2014-10-28 |
| 2014-06-30 | $788.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | -$1.90M 10-Q · filed 2014-07-29 | -$269.00K derived: sum of 3 quarters · filed 2014-07-29 | |
| 2014-03-31 | -$2.68M 10-Q · filed 2014-04-29 | -$1.06M derived: sum of 2 quarters · filed 2014-04-29 | ||
| 2013-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $754.00K 10-K · filed 2014-02-25 | ||
| 2013-09-30 | -$873.00K 10-Q · filed 2013-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |